$HIPH -News! Research/DD by See ThruEquity

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
361
$HIPH -News! Research/DD by See ThruEquity www.seethruequity.com/news/
Overview of research & press release out by See ThruEquity below.
.

NEW YORK, NY / ACCESSWIRE / June 21, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage on American Premium Water Corp. (OTC PINK: HIPH) with a Target Price of $0.15.

The report is available here: June 2018 Initiation Report.

We initiate coverage on American Premium Water Corp. (OTC PINK: HIPH, $0.020) with a price target of $0.15. HIPH is a diversified company focused on premium consumer brands and products. It currently sells and markets hydrogen-infused water under the LALPINATM brand and luxury apparel under the Gents brand. We expect HIPH growth to be supported by two commercial initiatives planned for this year: Hydrogen-infused Water and Hydrogen CBD-infused Water. Both product lines have high potential given: 1) the rising consumer interest in legal CBD products; and 2) the large and expanding market for functional water. LALPINATM Hydrogen is already selling via select channels, and the company is planning for a full-scale launch in the coming quarters. The company debuted LALPINATM Hydrogen CBD in January 2018, and it is expected to be launched in June 2018. The functional bottled water market in the US is expected to reach ~$2.9 billion by 2020 driven by a shift in consumer preference from soda-based to more nutritional and healthier drinks. This is evident from the rising demand of seltzer water, ionized water and smart water, among others. Hydrogen-infused water has the potential to become a new category in this trend. HIPH has an early mover advantage in the hydrogen infused water market which currently has limited competition.

LALPINA Hydrogen CBD positions the company to tap into growing consumer interest around CBD related products as this is the only known Hydrogen CBD water in the market. There is a large market opportunity given the growing number of cannabis dispensaries which could be potential customers.

We are also intrigued by management's effort to position Gents as an emerging luxury apparel brand. The recent acquisition of Worthy, a JV with China-based Zhangjiagang Advanced Company (ZAC), and collaborations with Showtime and SoulCycle should help expand footprint and consumer reach. HIPH has also entered the fast growing blockchain space via the acquisition of FashionCoinX, which further diversifies its potential revenue streams. HIPH noted a number of acquisition opportunities in the pipeline - all of which could further support growth. Going forward, we expect HIPH to increase revenues and earnings via new product launches, aggressive distribution and marketing, entry into new regions and M&A.

Well positioned as a luxury consumer lifestyle brand

HIPH manufactures and distributes consumer products under the LALPINATM and Gents brands. The LALPINATM brand focuses on hydrogen infused bottled water via its two products: LALPINATM Hydrogen (launched in 1Q18) and LALPINATM Hydrogen CBD (to be launched in June 2018). The bottled water market with functional benefits such as added alkalinity, electrolytes, vitamins, minerals is seeing significant traction among consumers. The shift in consumer preference to healthier and nutritional drinks is likely to further drive the growth of functional water market. The functional bottled water market in the US is expected to reach ~$2.9 billion by 2020. HIPH has an early mover advantage in the hydrogen infused water market which currently has limited competition. LALPINATM Hydrogen CBD is a front runner in the space as the only known hydrogen infused CBD beverage available on the market. The primary competitive advantage is that it improves bioavailability of CBD and absorption. The CBD market could reach $2.1 billion by 2020, according to Hemp Business Journal.

Gents is a producer of luxury hats and other fine accessories and apparel. Presence in 200 retail outlets internationally including upscale names such as Bloomingdale's, Nordstrom, and Saks Fifth Avenue strengthens its positions as a luxury brand. The acquisition of New York-based streetwear brand, Worthy further diversifies the apparel revenue stream. It will expand the price points offered by Gents and opens up many new distribution channels.

Expansion in blockchain/crypto space

The recent acquisition of FashionCoinX marks HIPH's entry in the fast growing blockchain/crypto space. Blockchain is one of the fastest growing technologies and entry in the space should benefit HIPH. According to Market Reports Center, the size of the blockchain industry will grow to $60.7 billion by the year 2024. HIPH is looking for more opportunities in the blockchain/crypto space that will complement its existing LALPINATM and Gents brands.

Aggressive marketing push to drive topline

HIPH plans to enter into partnerships and collaborations to increase distribution and marketing reach. The JV with China-based Zhangjiagang Advanced Company and collaborations with Showtime drama 'Billions' and fitness chain SoulCycle should help expand Gents footprint and consumer reach. Further, LALPINA's distribution agreement with GNC, one of the world's largest vendors of health and nutritional products, is likely to result in strong order flow. The management noted that it is working on several more distribution partnerships for both brands which should further bolster the topline.

Initiate coverage with a price target of $0.15

We see HIPH as a high risk and high reward consumer brand play. The target of $0.15 assumes that the company is successful in executing its organic and inorganic growth revolving around product expansion, strategic partnerships and M&A. Key risks include inability to raise capital for its growth initiatives and delay in the launch of LALPINATM Hydrogen CBD.

Please review important disclosures in the report and on our website at www.seethruequity.com.

About American Premium Water Corp.

HIPH is a manufacturer, distributor, and marketer of branded consumer products. It currently markets and distributes products under LALPINATM and Gents brands. Under the LALPINATM brand, the company develops hydrogen-infused energy products. Currently, the product line includes - 1) LALPINATM Hydrogen and 2) LALPINATM Hydrogen CBD. Gents is a producer of luxury hats and other fine accessories and apparel. The brand is carried in over 200 retail outlets internationally, including Bloomingdale's, Nordstrom, and Saks Fifth Avenue, among other boutiques and upscale retailers. For more information, visit www.americanpremiumwater.com

About SeeThruEquity

Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative approach to deliver equity research of microcap and smallcap companies. SeeThruEquity has also been the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion since 2012.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry's most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.

For more information visit www.seethruequity.com.

Contact:

SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 198

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 206

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading

Top 5 Most Recently Viewed Articles

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 558

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
ParaZero Technologies Achieves Nasdaq Compliance Milestone

Updated Category News Views 130

ParaZero Technologies Regains Compliance with Nasdaq Standards Recent developments in the aerospace sector have highlighted the impressive strides made by ParaZero Technologies Ltd. (Nasdaq: PRZO), an innovator in safety systems for drones and urban air mobility vehicles. The company has reached a significant milestone, regaining compliance with Nasdaq’s minimum bid...

Continue Reading
Revolutionizing Semiconductor Design with AI Integration

Updated Category News Views 389

Ricursive Intelligence Launches Groundbreaking AI Lab Ricursive Intelligence is setting a new standard in semiconductor design with the introduction of its innovative AI lab. This initiative aims to seamlessly blend artificial intelligence with chip creation to expedite progress within the tech landscape. Major Funding and Valuation Boost The company recently raised an...

Continue Reading
Craneware plc Publishes a Key Trading Disclosure Notice

Updated Category News Views 219

Introduction to Craneware plc's Trading Disclosure Craneware plc, a prominent player in the healthcare technology space, has officially announced a significant trading disclosure following the rules established in the Takeover Code. This notification serves as an important communication to stakeholders about recent trading activities that involve exempt principal traders...

Continue Reading
Stocks to Consider Amidst Global Market Uncertainty

Updated Category News Views 150

The Current Market Landscape As geopolitical tensions rise, markets are experiencing undercurrents of uncertainty. Recent tariff threats have sent ripples through global financial markets, particularly affecting investor confidence in stocks. The atmosphere is becoming increasingly cautious, with many investors wondering which stocks might shield their portfolios during...

Continue Reading